Abstract
Numerous factors including diet, lifestyle conditions, genetic background and physio-pathological conditions modulate the amplitude and time-courses of postprandial changes in humans. This review focuses on dietary factors affecting postprandial lipemia and lipoproteins metabolism in humans. The known effects of amount or type of fat, carbohydrate, protein and fiber are summarized. Changing the habitual dietary pattern can also alter the postprandial response. This review highlights that postprandial metabolism is a key link between dietary pattern and cardiovascular health or risk.
Keywords: Cardiovascular risk, chylomicrons, humans, nutrients, nutrition, postprandial lipemia, postprandial metabolism, fatty acids, genetic polymorphisms, hypertriglyceridemia, type 2 diabetes, cardiovascular disease
Current Vascular Pharmacology
Title: Effects of Nutrients on Postprandial Lipemia
Volume: 9 Issue: 3
Author(s): Denis Lairon and Catherine Defoort
Affiliation:
Keywords: Cardiovascular risk, chylomicrons, humans, nutrients, nutrition, postprandial lipemia, postprandial metabolism, fatty acids, genetic polymorphisms, hypertriglyceridemia, type 2 diabetes, cardiovascular disease
Abstract: Numerous factors including diet, lifestyle conditions, genetic background and physio-pathological conditions modulate the amplitude and time-courses of postprandial changes in humans. This review focuses on dietary factors affecting postprandial lipemia and lipoproteins metabolism in humans. The known effects of amount or type of fat, carbohydrate, protein and fiber are summarized. Changing the habitual dietary pattern can also alter the postprandial response. This review highlights that postprandial metabolism is a key link between dietary pattern and cardiovascular health or risk.
Export Options
About this article
Cite this article as:
Lairon Denis and Defoort Catherine, Effects of Nutrients on Postprandial Lipemia, Current Vascular Pharmacology 2011; 9 (3) . https://dx.doi.org/10.2174/157016111795495576
DOI https://dx.doi.org/10.2174/157016111795495576 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Opioid-induced Cardioprotection
Current Pharmaceutical Design Job Stress and Blood Pressure: A Critical Appraisal of Reported Studies
Current Hypertension Reviews The Entero-Hepatic Nuclear Receptors Integrate Cholesterol, Lipid, and Bile Acid Homeostasis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Tetracyclines: Drugs with Huge Therapeutic Potential
Mini-Reviews in Medicinal Chemistry The Coronary Collateral Circulation in Man
Current Cardiology Reviews Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?
Current Hypertension Reviews Preclinical Testing of Drug-Induced Proarrhythmia: Value of Transgenic Models
Cardiovascular & Hematological Agents in Medicinal Chemistry Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes
Current Pharmaceutical Design Approaches to the Management of Acute Kidney Injury in Children
Recent Patents on Biomarkers Comparison between Atorvastatin and Rosuvastatin on Secondary Percutaneous Coronary Intervention Rate and the Risk Factors in Patients with Coronary Heart Disease
Current Drug Metabolism Alzheimer’s Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome
Current Neuropharmacology C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?
Current Pharmaceutical Design Persistent Pulmonary Hypertension of the Newborn: Physiology, Hemodynamic Assessment and Novel Therapies
Current Pediatric Reviews Fibrinolytic Therapy in Acute Stroke
Current Cardiology Reviews Resistant Hypertension in the Elderly-Second Line Treatments: Aldosterone Antagonists, Central Alpha-Agonist Agents, Alpha-Adrenergic Receptor Blockers, Direct Vasodilators, and Exogenous Nitric Oxide Donors
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets Dietary Factors Influencing Magnesium Absorption in Humans
Current Nutrition & Food Science Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design New Strategies in Treatment of Mineral and Bone Disorders and Associated Cardiovascular Disease in Patients with Chronic Kidney Disease
Recent Patents on Cardiovascular Drug Discovery Traditional Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes Mellitus
Current Diabetes Reviews